|
|
||||||||
From the Day Neuromuscular Research Laboratory (Drs. Matsuda, Aoki, Ho, and Brown), Massachusetts General HospitalEast, Charlestown, MA; National Institute of Biosciences and Human Technology (Dr. Matsuda), Agency of Industrial Science and Technology, Tsukuba, Japan; Department of Neurology (Dr. Aoki), Tohoku University School of Medicine, Sendai, Japan; and Department of Neuromuscular Research (Y.K. Hayashi and Dr. Arahata), National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo, Japan.
Address correspondence and reprint requests to Dr. R.H. Brown, Jr., the Day Neuromuscular Research Laboratory, Massachusetts General HospitalEast, Room 6627, Building 149, 13th Street, Navy Yard, Charlestown, MA 02129.
Recently we reported that mutations in a muscle protein "dysferlin" are present in limb girdle muscular dystrophy2B and a related, adult-onset, distal dystrophy known as Miyoshi myopathy (MM). We report that antibodies to dysferlin identify a protein of approximately 230 kDa and show that dysferlin is located in the muscle membrane. This protein is absent in MM and LGMD-2B muscle. By contrast, dystrophin and other dystrophin-associated proteins are normal in these patients. Thus, dysferlin is a membrane-associated protein that is not likely to be an integral component of the dystrophin complex. Although it is not essential for initial myogenesis, it appears to be critical for sustained normal function in mature muscle.
Key words: DysferlinProteinMiyoshi myopathy.
This article has been cited by other articles:
![]() |
H. S. Ooi, C. Y. Kwo, M. Wildpaner, F. L. Sirota, B. Eisenhaber, S. Maurer-Stroh, W. C. Wong, A. Schleiffer, F. Eisenhaber, and G. Schneider ANNIE: integrated de novo protein sequence annotation Nucleic Acids Res., July 1, 2009; 37(suppl_2): W435 - W440. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Hernandez-Deviez, M. T. Howes, S. H. Laval, K. Bushby, J. F. Hancock, and R. G. Parton Caveolin Regulates Endocytosis of the Muscle Repair Protein, Dysferlin J. Biol. Chem., March 7, 2008; 283(10): 6476 - 6488. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nagaraju, R. Rawat, E. Veszelovszky, R. Thapliyal, A. Kesari, S. Sparks, N. Raben, P. Plotz, and E. P. Hoffman Dysferlin Deficiency Enhances Monocyte Phagocytosis: A Model for the Inflammatory Onset of Limb-Girdle Muscular Dystrophy 2B Am. J. Pathol., March 1, 2008; 172(3): 774 - 785. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Filosto, P. Tonin, G. Vattemi, L. Bertolasi, A. Simonati, N. Rizzuto, and G. Tomelleri The role of muscle biopsy in investigating isolated muscle pain Neurology, January 16, 2007; 68(3): 181 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pradhan Calf-head sign in miyoshi myopathy. Arch Neurol, October 1, 2006; 63(10): 1414 - 1417. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Hernandez-Deviez, S. Martin, S. H. Laval, H. P. Lo, S. T. Cooper, K. N. North, K. Bushby, and R. G. Parton Aberrant dysferlin trafficking in cells lacking caveolin or expressing dystrophy mutants of caveolin-3 Hum. Mol. Genet., January 1, 2006; 15(1): 129 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-S. Ro, G.-J. Lee-Chen, T.-C. Lin, Y.-R. Wu, C.-M. Chen, C.-Y. Lin, and S.-T. Chen Phenotypic Features and Genetic Findings in 2 Chinese Families With Miyoshi Distal Myopathy Arch Neurol, October 1, 2004; 61(10): 1594 - 1599. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ho, C. M. Post, L. R. Donahue, H. G.W. Lidov, R. T. Bronson, H. Goolsby, S. C. Watkins, G. A. Cox, and R. H. Brown Jr Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency Hum. Mol. Genet., September 15, 2004; 13(18): 1999 - 2010. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Lennon, A. Kho, B. J. Bacskai, S. L. Perlmutter, B. T. Hyman, and R. H. Brown Jr. Dysferlin Interacts with Annexins A1 and A2 and Mediates Sarcolemmal Wound-healing J. Biol. Chem., December 12, 2003; 278(50): 50466 - 50473. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. T. Cooper, H. P. Lo, and K. N. North Single section Western blot: Improving the molecular diagnosis of the muscular dystrophies Neurology, July 8, 2003; 61(1): 93 - 97. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takahashi, M. Aoki, M. Tateyama, E. Kondo, T. Mizuno, Y. Onodera, R. Takano, H. Kawai, K. Kamakura, H. Mochizuki, et al. Dysferlin mutations in Japanese Miyoshi myopathy: Relationship to phenotype Neurology, June 10, 2003; 60(11): 1799 - 1804. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Matsuda, Y. K. Hayashi, M. Ogawa, M. Aoki, K. Murayama, I. Nishino, I. Nonaka, K. Arahata, and R. H. B. Jr The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle Hum. Mol. Genet., August 1, 2001; 10(17): 1761 - 1766. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Aoki, J. Liu, I. Richard, R. Bashir, S. Britton, S. M. Keers, J. Oeltjen, H. E. V. Brown, S. Marchand, N. Bourg, et al. Genomic organization of the dysferlin gene and novel mutations in Miyoshi myopathy Neurology, July 24, 2001; 57(2): 271 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fanin, E. Pegoraro, C. Matsuda-Asada, R.H. Brown Jr., and C. Angelini Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathy Neurology, March 13, 2001; 56(5): 660 - 665. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |